Document is current
Any future updates will be listed below
-
Authors
Molina-Lopez, Cristina
Hurtado-Navarro, Laura
O’Neill, Luke A. J.
Pelegrin, Pablo https://orcid.org/0000-0002-9688-1804
-
Funding
Funding for this research was provided by:
Ministerio de Ciencia e Innovación (PID2020-116709RB-I00, CNS2022-135105)
Fundación Séneca (21897/PI/22)
Universidad de Murcia
- License Information
-
More Information
Article History
Received: 30 October 2024
Revised: 27 March 2025
Accepted: 6 April 2025
First Online: 23 May 2025
Declarations
:
: P.P. declares that he is an inventor on a patent filled in March 2020 by the Fundación para la Formación e Investigación Sanitaria de la Región de Murcia (PCT/EP2020/056729) for a method to identify NLRP3-immunocompromised sepsis patients. P.P. and L.H-N. are co-founders of Viva in vitro diagnostics SL, but declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The remaining authors declare no competing interests.
